VDO Biotech
VDO Biotech Co., Ltd. is a high-tech enterprise dedicated to innovative microsphere technologies and the production of a variety of high-quality microsphere products for global customers. Founded in 2014 and headquartered in the Suzhou Industrial Park BioBAY, the company drives innovation through its integrated portfolio of high-performance microsphere technologies, separation & purification solutions, and nano-flow cytometry.
Focused on the IVD and biopharmaceutical sectors, VDO delivers end-to-end solutions from core raw materials to process optimization. Our offerings include:
IVD Microspheres: Magnetic Microspheres, Latex Microspheres, Dyed Microspheres, Fluorescent Microspheres, Flow Cytometry Microspheres
Chromatography Resins: Affinity Resins, Ion Exchange Resins, Size Exclusion Resins, Hydrophobic Interaction Resins
Homogeneous Luminescent Immunoassay: Homogeneous Reagents, Homogeneous Instrument, Homogeneous Consumables
Exoplorer Nano-flow Cytometer
Applications span molecular diagnostics, immunoassays, and large-scale biopharmaceutical purification. With ISO 9001:2015-certified manufacturing and a 10,000㎡ R&D & production base, VDO ensures consistent quality and supply reliability. Serving 50+ countries, our products and technical services are trusted by global partners in life sciences and diagnostics.

more >
Year of Establishment:
2014
Total Number of Staff:
100-500
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Other Competitive Advantages:
1. End-to-End Microsphere Technology Leader
Dual-technology platform covering both IVD microspheres (magnetic/fluorescent/latex) and biopharma chromatography resins (affinity/ion exchange/multimodal). Industrial-scale production with 10,000㎡ ISO 9001:2015 certified facility ensuring full-process quality control.
2. Integrated IVD & Biopharma Solutions
Complete IVD ecosystem from antibody raw materials to microsphere conjugation and assay development. Turnkey purification solutions combining chromatography resins with process optimization services.
3. Cutting-Edge R&D Capabilities
23 patents portfolio (6 granted + 17 pending) led by senior scientists in state-certified high-tech enterprise. Customization expertise in surface modification, pre-conjugated microspheres, and specialty resin development.
4. Global Supply Chain Strength
Dual offering of quality materials + technical services with worldwide OEM support.
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Africa
Advantage Description: